Activation of human lung semicarbazide sensitive amine oxidase by a low molecular weight component present in human plasma.
Semicarbazide-sensitive amine oxidase (SSAO) encodes a wide family of enzymes named E.C.1.4.3.6 [amine:oxygen oxidoreductase (deaminating) (copper containing)] that metabolises primary aliphatic and aromatic amines. It is present in almost all vascularised and nonvascularised mammalian tissues, and it is also present in soluble form in plasma. SSAO appears to show different functions depending on the tissue where it is expressed. Here we describe, for the first time, the activation of the SSAO from human lung by human plasma. The extent of activation was greater when the human plasma came from diabetic and heart infarcted patients. A kinetic mechanism of such effect is proposed. The activation was lost after the plasma was dialysed, indicating a low molecular weight component (MW <3800 Da) to be responsible. The activator component is heat stable and resistant to proteolysis by chymotrypsin and trypsin and also resistant to perchloric acid treatment. However, treatment with 35% formic acid, completely abolished activation, suggesting involvement of lipid material. The possibility of that lysophosphatidylcholine (LPC), an amphiphilic phospholipid derived from the phosphatidylcholine, the major component in plasma accumulated in pathological conditions, was studied. LPC was shown to behave as a "competitive activator" of human lung SSAO at concentrations below its critical micellar concentration (CMC value=50 microM). Thus LPC may be a component of the SSAO activatory material present in human plasma.
Dalfó
E
E
Departament de Bioquímica i Biología Molecular, Institut de Neurociencies, Facultat de Medicina, Universitat Autónoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.
Hernandez
M
M
Lizcano
J M
JM
Tipton
K F
KF
Unzeta
M
M
D006631:Amine Oxidase (Copper-Containing) / Q000097:blood / Q000737:chemistry / Q000378:metabolism*; D002056:Burns / Q000097:blood; D003920:Diabetes Mellitus / Q000097:blood; D004789:Enzyme Activation / Q000187:drug effects; D004795:Enzyme Stability; D006801:Humans; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007700:Kinetics; D008168:Lung / Q000187:drug effects / Q000201:enzymology*; D008244:Lysophosphatidylcholines / Q000494:pharmacology; D009203:Myocardial Infarction / Q000097:blood; D010743:Phospholipids / Q000097:blood / Q000378:metabolism*
D008244:Lysophosphatidylcholines; D010743:Phospholipids; D006631:Amine Oxidase (Copper-Containing)